Phase 4 Regurgitation Clinical Trials
8 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–8 of 8 trials
Recruiting
Phase 4
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant
Mitral Regurgitation
Chinese Academy of Medical Sciences, Fuwai Hospital1,032 enrolled1 locationNCT07007143
Recruiting
Phase 4
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant
Mitral Regurgitation
Chinese Academy of Medical Sciences, Fuwai Hospital880 enrolled1 locationNCT06901466
Recruiting
Phase 4
TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System
AORTIC VALVE DISEASESTranscatheter Aortic Valve Replacement (TAVR)aortic regurgitation
Ruijin Hospital120 enrolled4 locationsNCT06818084
Recruiting
Phase 4
Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
Coronary Artery DiseaseIschemic Mitral RegurgitationAngiotensin Receptor/Neprilysin Inhibitor
China National Center for Cardiovascular Diseases220 enrolled1 locationNCT06917664
Recruiting
Phase 4
Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.
Heart Valve DiseasesHeart Failure, CongestiveLeft Ventricle Remodeling+2 more
Vitor Emer Egypto Rosa60 enrolled1 locationNCT07099859
Recruiting
Phase 4
Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial
Congenital Heart DiseasePulmonary RegurgitationRepaired Tetralogy of Fallot (rTOF)+2 more
The University of Hong Kong106 enrolled1 locationNCT06668389
Completed
Phase 4
A study to compare 2 methods of inserting a pulmonary artery catheter in high risk cardiac surgical patients.
Severe left ventricular systolic dysfunctionMitral valve disease with severe pulmonary hypertensionHigh risk cardiac surgical patients+1 more
Austin Hopsital50 enrolled1 locationACTRN12614001081606
Not Yet Recruiting
Phase 3Phase 4
A randomised cross-over study of effects of vasodilator treatment on left ventricular mass and volume in patients with chronic aortic regurgitation
aortic regurgitation
National Heart Foundation of NZ25 enrolled1 locationACTRN12610000753055